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Integrated Microfluidic Isolation 
of Aptamers Using Electrophoretic 
Oligonucleotide Manipulation
Jinho Kim1,*, Timothy R. Olsen1,*, Jing Zhu1, John P. Hilton1, Kyung-Ae Yang2, Renjun Pei3, 
Milan N. Stojanovic2 & Qiao Lin1
We present a microfluidic approach to integrated isolation of DNA aptamers via systematic evolution 
of ligands by exponential enrichment (SELEX). The approach employs a microbead-based protocol 
for the processes of affinity selection and amplification of target-binding oligonucleotides, and an 
electrophoretic DNA manipulation scheme for the coupling of these processes, which are required to 
occur in different buffers. This achieves the full microfluidic integration of SELEX, thereby enabling 
highly efficient isolation of aptamers in drastically reduced times and with minimized consumption of 
biological material. The approach as such also offers broad target applicability by allowing selection 
of aptamers with respect to targets that are either surface-immobilized or solution-borne, potentially 
allowing aptamers to be developed as readily available affinity reagents for a wide range of targets. 
We demonstrate the utility of this approach on two different procedures, respectively for isolating 
aptamers against a surface-immobilized protein (immunoglobulin E) and a solution-phase small 
molecule (bisboronic acid in the presence of glucose). In both cases aptamer candidates were isolated in 
three rounds of SELEX within a total process time of approximately 10 hours.
Aptamers are synthetic oligonucleotide-based receptors that bind to biochemical targets1, and are isolated from 
libraries of randomized oligonucleotides through an iterative in vitro selection and amplification process termed 
systematic evolution of ligands by exponential enrichment (SELEX)2,3. Aptamers offer an attractive alterna-
tive to other receptors such as antibodies4, as they are synthetically available for a diverse range of targets (e.g., 
small molecules, peptides, amino acids, proteins, cells, viruses, and bacteria), are reproducible with minimal 
batch-to-batch variations, and are stable with excellent shelf life2,5–7. Aptamers can also be designed to bind to 
targets in specific functional domains8,9 or with predefined kinetic or equilibrium binding characteristics10–13. 
Additionally, aptamers are amenable to chemical conjugation with other molecules (e.g., diagnostic and thera-
peutic agents)14,15, and are potentially low in immunogenicity (when used in vivo) due to their small size4. Broad 
applications have been explored for aptamers in basic biological sciences, drug discovery, clinical diagnostics and 
therapeutics, and other fields16,17.
Conventional SELEX procedures involve repeated (10–20 rounds) execution of manual, tube-based processes 
such as mixing of oligonucleotides with targets, partitioning of binding oligonucleotides from non-binders, elu-
tion and amplification of binding oligonucleotides, and purification of the amplified product2,3. Completion of 
these processes typically require a month or longer of laborious work by highly trained personnel1,18. Robotic 
automation, while alleviating the labor-intensiveness of the manual procedures, is prohibitive and impractical for 
individual non-specialist laboratories19. Capillary electrophoresis-based methods can reduce the overall SELEX 
process time down to several days;20 however, they still require significant manual handling on the basis of a 
highly specialized set of skills, and are not well suited to very large (e.g., cell7) or small21 (e.g., small molecule) 
targets. As a result, aptamers are not yet routinely available for use in non-specialist laboratories.
There has been emerging effort to apply microfluidic technology to aptamer isolation. Microfluidic affin-
ity selection has been performed, in conjunction with off-chip amplification, against targets retained using 
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silica capillary walls22, microbeads23–28 or sol-gels29–31, or against cells in solution32,33, to increase selection strin-
gency23–27,32,33, create more favorable biomolecular environments29–31, or allow simultaneous positive and negative 
selections28. Soh and coworkers, focusing solely on the affinity selection stage of SELEX, incubated oligonucle-
otides with target-functionalized magnetic beads, which were then purified in a continuous-flow fashion in a 
microchannel. This allowed highly efficient affinity selection of aptamer candidates, which were next amplified 
using off-chip PCR instrumentation. Similarly, Kim and coworkers performed affinity selection of oligonucleo-
tides against targets such as proteins and small molecules that were immobilized in sol-gels. These oligonucleo-
tides were next, again, amplified off-chip. Aiming to integrate the overall SELEX process, Lee and coworkers used 
pneumatically based flow control in microchips for isolation of aptamers targeting viruses34, cells27,35,36 and pro-
teins37,38. While capable of performing individual affinity selection and PCR amplification processes on-chip, the 
microchips apparently required an off-chip procedure to retrieve single-stranded DNA from amplified products 
between successive rounds of SELEX, and thus did not allow full integration of SELEX. In addition, these devices 
were mostly limited to targets (e.g., proteins and cells) that are readily surface-immobilizable, and were in general 
not applicable to targets (e.g., small molecules) whose immobilization is difficult and against which isolation of 
aptamers is challenging39,40.
We present an approach to microfluidic SELEX that fully integrates all steps of the SELEX process on a single 
microchip. The approach is based on two engineering innovations: a fully bead-based protocol that applies to 
affinity selection and PCR amplification, and electrophoretic coupling of affinity selection and PCR amplification, 
two major phases of each SELEX round that are required to occur in different buffers. These innovations, which 
to our knowledge have not been demonstrated in existing microfluidic SELEX efforts, significantly simplify the 
manipulation of target molecules and oligonucleotides (e.g., retention, separation, and retrieval) as well as buffers 
(e.g., replenishment and replacement). More importantly, they critically enable the on-chip coupling of successive 
SELEX rounds and achieve the full microfluidic integration of the SELEX process, thereby enabling highly effi-
cient isolation of aptamers in drastically reduced times and with minimized consumption of biological material. 
The bead-based SELEX protocol also affords broad target applicability by allowing selection of aptamers with 
respect to targets that are either surface-immobilized or solution-borne. As such, the approach is in principle 
applicable to virtually any form of target (e.g., small molecules, proteins, cells, viruses, and bacteria), potentially 
allowing aptamers to be developed as broadly applicable affinity reagents.
We demonstrate the utility of our microfluidic SELEX approach by isolating DNA aptamers in two procedures 
with (i) a target protein on microbeads and an oligonucleotide library in solution, and (ii) a small-molecule target 
in solution and an oligonucleotide library immobilized on microbeads. These protocols were successfully applied, 
respectively, to isolate oligonucleotides that bind to immunoglobulin E (IgE) protein on beads and oligonucle-
otides that are released from beads in the presence of bisboronic acid-glucose complexes (a modified Shinkai 
receptor-monosaccharide complex41). These results show the potential of our microfluidic SELEX approach for 
efficient, automated and rapid isolation of aptamers as readily available and broadly applicable affinity reagents 
in biomedical applications.
Experimental Section
Integrated Aptamer Isolation. Our approach to integrated aptamer isolation is based on a microchip, 
which consists of two microchambers (respectively referred to as the selection and amplification chambers, 5 μ L 
each in volume) interconnected by a microchannel (length: 7 mm, width: 1 mm, height: 300 μ m) (Fig. 1e). Each 
chamber is integrated with a weir-like flow constriction (weir height: 40 μ m) to retain microbeads, and with 
a resistive micro heater and temperature sensor (Cr/Au: 5 nm/100 nm) for temperature control (Fig. 1f). The 
microchannel is filled with an agarose gel that allows electrophoresis of oligonucleotides while preventing bulk 
flow (Supplementary Information, Figure S3).
The entire SELEX process for aptamer isolation is integrated on the microchip, using a bead-based protocol 
for both affinity selection and amplification, via polymerase chain reaction (PCR), of target-binding oligonucle-
otides. Affinity selection can be performed against a target that is either surface-immobilized or solution-borne 
in the selection chamber. In the former case, a library of randomized single-stranded DNA (ssDNA) oligonucle-
otides in solution is incubated with a target (e.g., protein) that is attached to microbeads, allowing those strands 
of sufficient affinity to bind to the target. Following removal of weakly and non-binding strands with buffer 
wash, the strong binders are thermally released from the beads (Fig. 1a and Figure S1a). On the other hand, 
affinity selection for a target not amenable to surface-immobilization (e.g., a small molecule) occurs in solution 
phase. The solution-borne target is incubated with randomized oligonucleotides immobilized by hybridization to 
a short ssDNA strand that is attached to microbeads and serves as an anchor (Fig. 1b). Target-binding oligonu-
cleotides are released from the surfaces if the oligomer-target affinity is greater than the oligomer-anchor affinity 
(Figure S1b). In both affinity selection schemes, target-binding oligonucleotides are released into the buffer and 
transferred, via electrophoretic transport through the gel-filled interconnecting channel, into the amplification 
chamber, and captured via hybridization by a reverse primer immobilized on microbeads therein42,43 (Fig. 1c).
The target-binding oligonucleotides are then amplified by PCR on microbeads44 (Fig. 1d and Supplementary 
Information Figure S2). The initial PCR cycle produces the complimentary strand to the target-binding oligo-
nucleotides, resulting in double stranded DNA (dsDNA) attached to the beads. Subsequent cycles, additionally 
using a solution-borne forward primer, produce duplicate copies of the double stranded DNA (dsDNA). Thus, 
the final PCR product is in the form of bead-immobilized dsDNA where the target-binding oligonucleotides are 
hybridized to their complementary strands, which are in turn immobilized on bead surfaces. The dsDNA is split 
into single strands by chemical denaturation, releasing the amplified target-binding oligonucleotides into the 
solution while their complementary strands remain tethered to the bead surfaces. The amplified target binders 
are electrophoretically transported, again through the gel-filled interconnection channel, back into the selec-
tion chamber, where they are further affinity selected as described above. This procedure is repeated in multiple 
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rounds to generate a pool of enriched target-binding oligonucleotides. Thus, the entire iterative SELEX process is 
integrated on a single chip and does not require any offline procedures, thanks to on-chip coupling of successive 
SELEX rounds as critically enabled by the bead-based PCR protocol. The enriched aptamer pools were cloned and 
sequenced to identify unique ssDNA sequences for each target.
Microchip Fabrication and Testing. The microchip was fabricated of poly(dimethylsiloxane) (PDMS) for 
proof of principle, although other materials could readily be used to implement our approach. In the fabrication 
process, SU-8 photoresist was used to form a mold on a silicon substrate defining the microfluidic features. A 
prepolymer solution of PDMS was poured onto the mold, cured on a hotplate. The resulting PDMS sheet was 
released from the mold, and bonded onto a glass substrate that had been fabricated with Cr/Au heaters and tem-
perature sensors. Finally, the interconnection channel between the chambers was filled with a molten 4% agarose 
gel and allowed to cure at room temperature (Fig. 1g).
In SELEX experiments, the target, ssDNA library, and PCR reagents were introduced into and removed from 
each microchamber using a syringe pump (NE-1000, New Era Pump Systems Inc.), at a flow rate of 10 μ L/min 
unless otherwise noted. The pumps were manually controlled for demonstration of principle (although they could 
be readily programmed and automated, or replaced with established micropumps and valves45–47) and were not 
required for the coupling of successive rounds of SELEX, which was realized on-chip by the bead-based protocol 
as described above. The electric field (25 V/cm) for electrophoresis was generated in the interconnection channel 
by applying a voltage (from the power supply) to platinum (Pt)-wire electrodes inserted into the bead inlets. 
The temperature in each chamber was controlled within ± 0.5 °C using the integrated heater and temperature 
sensors by a LabVIEW-based proportional-integral-derivative (PID) controller that was connected to a mul-
timeter (34410A, Agilent Technologies) and a power supply (E3631A, Agilent Technologies) (Supplementary 
Information, Figure S4)44.
Affinity selection was performed at 25 °C. Microbeads functionalized with the target (for protein targets) 
or bearing the ssDNA library (for small-molecule targets) were injected into the selection chamber until they 
occupied approximately 50% of the chamber volume. Then the ssDNA library (1 μ M in selection buffer, for 
protein targets) or target solution (1 μ M in selection buffer, for small molecules) was infused into the cham-
ber and incubated with the beads for 10 minutes. Additionally for protein targets, wash buffer was infused into 
the chamber (20 μ L/min) to remove weakly binding ssDNA, followed by raising the chamber temperature to 
57 °C to release protein binder into the solution. Next, reverse primer-functionalized beads were introduced into 
the amplification chamber to occupy approximately 50% of the chamber volume. An electric field was applied 
Figure 1. Integrated microfluidic SELEX. On microbeads, oligonucleotides are selected against a (a) surface-
immobilized or (b) solution-phase target. Strong binders to the target are transferred away electrophoretically 
(c), and are subsequently captured and then amplified via PCR on microbeads (d), with the product transferred 
back electrophoretically to start a new round of affinity selection. This principle is implemented in a microchip 
consisting of the selection and amplification microchambers each integrated with a resistive heater and 
temperature sensor, and interconnected by a gel-filled microchannel: (e) top and (f) cross-sectional schematics. 
A micrograph of the microchip is shown in (g), with microbeads retained in the microchambers and agarose 
gel (dyed blue for visualization) filling the interconnection channel. Inset: Micrograph of the weir-like flow 
constriction region with retained beads.
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to electrophoretically transfer binding oligonucleotides to the amplification chamber. PCR reagents were then 
introduced into the chamber, followed by PCR thermal cycling (20 cycles) using on-chip temperature control. 
Meanwhile, the beads in the selection chamber were replaced with either fresh target functionalized beads (for 
protein targets) or beads with complimentary ssDNA anchors (for small-molecule targets). Following completion 
of PCR, 0.2 M NaOH was introduced into the amplification chamber to release the target-binding ssDNA, which 
was then transferred, using an an electric field, back to the selection chamber for affinity selection of the next 
SELEX round. The detailed on-chip SELEX procedure for protein and small molecule targets can be found in 
the Supporting Information (Tables S1 and S2). The process time, including the time to condition the microchip 
(e.g., introducing the gel) and to complete the SELEX process (from the introduction of beads to the output of 
the aptamer candidates), took approximately 10 hours. While the entire iterative SELEX process was performed 
on-chip, buffer washes were collected from the individual stages of each round, and oligonucleotides therein were 
amplified via off-chip PCR using a thermocycler (Eppendorf Mastercycler Gradient, Eppendorf) and analyzed via 
gel electrophoresis to characterize the SELEX process.
Chemicals and Reagents. The randomized ssDNA library and primers were purchased from Integrated 
DNA Technologies. The DNA library used in aptamer selection for IgE protein were labeled with fluorescein 
(Excitation/Emission: 495 nm/520 nm) and contained a randomized region of 40 bases flanked by 24- and 23-base 
primer regions for the PCR amplification (5′ -GCC TGT TGT GAG CCT CCT GTC GAA -40N -TTG AGC GTT 
TAT TCT TGT CTC CC-3′ ). The ssDNA library used in aptamer selection against bisboronic acid-glucose mix-
tures contained a randomized region of 30 bases flanked by 18- and 24-base primer regions (5′ -GGA GGC TCTC 
GGG ACG AC -30N-GTC GTC CCG ATG CTG CAA TCG TAA-3′ ), while the corresponding anchor for bead 
immobilization was a biotinylated 19-mer ssDNA (3′ -ATA TCC GAG AGC CCT GCT G-5′ ). NHS-activated aga-
rose microbeads (diameter: 45–165 μ m with a mean of 90 μ m) and streptavidin-functionalized agarose microbe-
ads (diameter: 50–80 μ m) were obtained from GE Healthcare Life Sciences and Thermo Scientific, respectively. 
Human IgE and IgG proteins were purchased from Athens Research and Sigma-Aldrich, respectively. Chemicals 
for preparation of selection buffers (44.5 mM Tris base, 44.5 mM bisboronic acid, 50 mM NaCl, pH 8.5) and 
elution buffers (44.5 mM Tris base, 44.5 mM bisboronic acid, 50 mM NaCl, 0.2 M NaOH) for protein and small 
molecule were purchased from Sigma-Aldrich.
To prepare IgE-functionalized beads, NHS activated agarose beads (200 μ L) were washed 3 times in a column 
with selection buffer. The beads were then incubated with 5.7 μ M IgE (35 μ L) at room temperature for 5 h on a 
shaker and washed 3 times with selection buffer. To block the NHS binding sites not occupied by IgE, the beads 
were incubated with 0.1M Tris-HCl buffer at room temperature for 1 h followed by washing 3 times with selec-
tion buffer. The IgE functionalized beads were stored in selection buffer in a refrigerator (4 °C). Microbeads for 
aptamer selection against bisboronic acid-glucose mixtures were prepared by incubating 500 pmol of biotiny-
lated ssDNA anchor with 50 μ L of streptavidin-functionalized agarose beads at room temperature for 30 minutes. 
Following the incubation, the beads were washed 3 times with selection buffer and incubated with 100 pmole 
of the ssDNA library for 30 minutes, which had previously been heated at 95 °C for 5 minutes and then held at 
room temperature for ~15 minutes. The beads were then washed with selection buffer and stored in a refrigerator. 
Similarly, beads for PCR amplification were prepared by incubating 100 pmole of biotinylated reverse primer with 
50 μ L of streptavidin-functionalized beads.
To prepare bisboronic acid-glucose molecule mixtures, 4 μ L of 2.5 mM bisboronic acid was mixed with 10 μ L 
of 1 M glucose in 186 μ L of selection buffer. The final mixture of 50 μ M bisboronic acid and 50 mM glucose was 
incubated for 20 minutes at room temperature before each experiment.
Binding Measurements. A standard fluorescence-binding assay was used to measure the binding affinity of 
aptamer candidates to IgE. The fluorescently labeled enriched aptamer pool and individual sequences identified 
through sequencing were prepared at varying concentrations (0–100 nM) in selection buffer (total volume: 100 μ L). 
IgE-functionalized beads in tubes (3 × 104 per tube) were washed with selection buffer and incubated with the 
DNA strands at room temperature for 2 h. Following the incubation, the beads were washed with selection buffer 
three times to remove unbound oligonucleotides. The tubes containing beads were heated at 95 °C for 10 min. 
Oligonucleotides eluted from the beads were collected and quantified using a plate reader. The fluorescence inten-
sity data were analyzed to estimate the dissociation constant (KD) by nonlinear regression using Origin (Origin 
Lab Corporation). To estimate binding affinity for the bisboronic acid-glucose mixture, microbeads functional-
ized with the enriched pool or with particular sequences from the pool were incubated with different concentra-
tions of the mixture (0–12.5 μ M) at room temperature for 30 minutes. Oligonucleotides released from the beads 
by binding to the target were collected and amplified. Gel images of the amplification product were obtained fol-
lowing gel electrophoresis, and the intensities of the gel bands were analyzed, using ImageJ software, to determine 
the amount of DNA released. The amount of DNA released was analyzed to estimate the dissociation constant 
using Origin.
Results and Discussion
We first present results from characterization of the individual analytical procedures, and then those from the 
integrated aptamer isolation process as well as target-binding affinity measurements for the resulting aptamers. 
The IgE antibody was used48 as a representative surface-immobilized target, while bisboronic acid mixed with 
glucose (BA-glucose mixture) was used as a representative solution-borne target39.
Affinity Selection. We first characterized affinity selection of a randomized oligonucleotide library against 
targets. Eluates collected from the selection chamber during affinity selection were PCR amplified and analyzed 
using conventional gel electrophoresis (Fig. 2). The progress of affinity selection was investigated by comparing 
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the fluorescence intensities of the bands in gel images, which were indicative of the amount of ssDNA in the elu-
ates loaded in the corresponding gel lane.
For protein targets, the library was introduced into the selection chamber that contained protein-functionalized 
beads. The chamber was then washed with 10 buffer washes (~33 μ L) to remove weakly binding ssDNA. The band 
intensity for the 10 buffer washes (W1–W10) in the gel image decreased with the wash number, indicating that 
weakly and non-binding oligonucleotides were successively removed from the microbeads and the chamber. On 
the other hand, the band intensity for the elution lane (E) increased to ~2.5 times that for the final wash (W10) as 
oligonucleotides that strongly bound to the bead-immobilized IgE were released. These oligonucleotides specif-
ically bound to IgE rather than nonspecifically adsorbed to the chamber or bead surfaces, as no visible band was 
seen for the elution lane in the control experiment performed using bare beads (Fig. 2a).
For affinity selection against the BA-glucose mixture, the library was introduced into the selection chamber, 
which had been preloaded with capture beads. Oligonucleotides not captured by the bead-immobilized anchor 
were removed from the chamber during two initial buffer washes and collected (W1 and W2). Then a counter 
target (bisbornonic acid) was introduced and the eluate was collected. The band with relatively high fluorescence 
intensity for the eluate obtained during counter selection (C) indicated that strands that bound only to the bis-
boronic acid (used as a counter target) were eliminated. Oligonucleotides that still remained in solution were 
removed with continuous buffer washes (W3–W12), followed by the release and elution of target-binding oligonu-
cleotides upon introduction of the target molecule, as indicated by the strong intensity for the elution band (E), 
which was ~6 times greater than that for the final wash (W12) (Fig. 2b).
Electrophoretic Oligonucleotide Transfer. We characterized electrophoretic transfer of target-binding 
oligonucleotides from the selection chamber to the amplification chamber, and their subsequent capture onto 
microbeads. This process will be used to enable the on-chip coupling of affinity selection and amplification of 
target-binding oligonucleotides in any given SELEX round. Fluorescently labelled oligonucleotides, obtained 
from affinity selection against IgE in the selection chamber, were electrophoretically driven through the gel-filled 
interconnection channel into the amplification chamber. The fluorescent intensity, and hence the amount, of 
oligonucleotides passing by the channel’s midpoint increased steadily from the time t = 7 min following the appli-
cation of the electric field. The amount of electrophoresed oligomers maximized at t = 10 min, and then gradu-
ally decreased but remained visible until t = 15 min (Fig. 3a). In addition, the oligonucleotides were captured by 
reverse primers immobilized on microbeads in the amplification chamber, as indicated by the strong fluorescence 
intensity of the beads compared to that of bare beads used as control (Fig. 3b).
Similarly, oligonucleotides selected using the BA-glucose mixture were electrophsoretically transferred and 
captured onto microbeads placed in the amplification chamber, as a strong band was seen in the first elution 
lane (E) in the gel image obtained using the eluates following the electrophoretic transfer and capture processes 
Figure 2. Microfluidic affinity selection of target-binding oligonucleotides. Bar graphs and representative 
gel images depict the relative band intensity in the gel image (inset) of eluate obtained during affinity selection 
for (a) IgE and (b) BA-glucose mixture. As control, bare beads were used for the affinity selection experiments 
for IgE. Bisboronic acid was used as a counter target for isolating aptamers targeting the BA-glucose mixture. 
Lane W: wash; Lane E: elution; Lane C: counter selection. All experiments were repeated three or more times 
(Supplementary Information, Figures S11, S12 and S13) with standard errors indicated with error bars.
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(Fig. 3c). In the experiments, no significant damage to the gel was observed even after the electric field was applied 
for as long as ~180 minutes, suggesting that electrophoretic transfer of oligonucleotides could be performed 
repeatedly in the chip as required by the multi-round SELEX process (Supplementary Information, Figure S5).
Bead-Based PCR and On-Chip Coupling of Successive SELEX Rounds. We characterized 
bead-based PCR and its use to enable on-chip coupling of PCR amplification in one SELEX round and affinity 
selection in the immediately following SELEX round. Oligonucleotides captured by the bead-immobilized reverse 
primers were amplified via bead-based PCR using fluorescently labeled forward primers in the amplification 
chamber (Supplementary Information, Figure S2). The fluorescence intensity of the bead-bound dsDNA PCR 
product exhibited a sigmoidal dependence on the number of PCR thermal cycles, as typically observed in PCR on 
solid surfaces49 (Fig. 3d). During the initial ~10 PCR cycles, the bead fluorescence intensity increased exponen-
tially. Between ~10 and ~20 PCR cycles, the bead fluorescence intensity increased much more slowly, indicating a 
decreased rate of PCR product generation likely due to a decreasing amount of bead-immobilized reverse primers 
available for the reaction50. Beyond ~20 cycles, the increase in fluorescence intensity became insignificant as the 
majority of reverse primers had already been converted into dsDNA PCR product. Thus, the maximum amount 
of oligonucleotides, which would be used for further affinity selection, could be produced using approximately 
25 PCR cycles in our chips. Although a greater number of PCR cycles was used than usual, overamplification 
of non-specific binders was not considered significant51 because the amount of oligonucleotides amplified on 
beads was typically much smaller than conventional solution-based PCR52. We also verified that the amplification 
chamber could be repeatedly used for amplifying target-binding oligonucleotides during the iterative aptamer 
isolation processes (Supplementary Information, Figure S6).
To couple PCR amplification in one SELEX round with affinity selection in the next round, the oligonucleo-
tides amplified in the amplification chamber were transferred electrophoretically back to the selection chamber, 
where they were further affinity selected. The bright bands in the gel images for the eluate collected during the 
first buffer wash (W1) following the application of the electric field indicated that this new round of affinity selec-
tion was successful for IgE (Fig. 3e) and for the BA-glucose mixture (Fig. 3f). For the affinity selection towards 
IgE, the gradual decrease in the band intensity with the buffer wash number shows the removal of oligonucleo-
tides that less strongly bound to the target compared with those that remained on beads. For the affinity selection 
against BA-glucose mixture, the band intensity decreased with the mixture washes, showing that the target com-
petitively bound to and released ssDNA from bead-immobilized anchors.
Multi-Round Microfluidic SELEX. Having characterized the individual procedures, we tested inte-
grated multi-round SELEX for isolation of DNA aptamers. To minimize potential issues associated with 
electrolysis-induced pH changes of buffers during the electrophoretic transfer process53, fresh selection buffer 
was infused (1 μ L/min) continuously into the chip’s anode port (Supplementary Information, Figure S7). Using 
Figure 3. Characterization of electrophoretic transfer and bead-based PCR amplification of target-binding 
oligonucleotides. (a) Fluorescence intensity measurements at the center of the gel-filled interconnection 
channel as fluorescently labeled IgE-binding oligonucleotides migrated from the selection chamber to the 
amplification chamber. (b) Fluorescence measurements of IgE-binding strands that were electrophoretically 
transferred to and captured by bead-immobilized reverse primers in the amplification chamber. Scale bars: 
100 μ m. (c) Gel electropherogram of oligonucleotides targeting the BA-glucose mixture eluted from the chip, 
following their electrophoretic transfer to, capture by, and subsequent thermal release from bead-immobilized 
reverse primers in the amplification chamber. (d) Fluorescence intensity of IgE-binding oligonucleotides 
amplified on beads following different numbers of PCR cycles. Affinity selection of PCR-amplified 
oligonucleotides against (e) IgE and (f) the BA-glucose mixture. Lane W: wash and Lane E: elution.
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a microchip, the isolation of protein-binding aptamer candidates was demonstrated with three rounds of affinity 
selection and amplification against IgE, followed by counter selection against human immunoglobulin G (IgG), to 
which the aptamer candidates were sought not to bind (Figure S8a). With an increasing number of buffer washes, 
the band intensities decreased from the initial wash (W1) to the final wash (W10) by approximately 55%, 98%, and 
91% in SELEX rounds 1, 2, and 3, respectively, indicating the removal of weakly and non-binding oligonucleo-
tides. The weaker band intensity for the initial wash (W1) in round 3 compared with that in rounds 1 and 2 could 
be attributed to the improvement in the affinities of oligonucleotides to IgE. Following counter selection against 
IgG, a pool of enriched IgE-binding oligonucleotides was obtained, as indicated by a distinct band (E) (Fig. 4a).
Three rounds of microfluidic SELEX were also performed using the BA-glucose mixture, with counter selec-
tion against bisboronic acid alone included in rounds 2 and 3. In round 1, oligonucleotides that were not captured 
by the bead-immobilized anchor were removed from the selection chamber (W1–W10). Discernible bands for the 
counter target (C) in rounds 2 and 3 indicated that strands that bound to bisboronic acid alone were removed. 
Oligonucleotides remaining in solution in the chamber were removed with further buffer washes, as indicated 
by the band intensity for the final wash (W10) from rounds 2 and 3 decreasing by approximately 71% and 88% 
relative to the initial wash (W1) of each round. The band intensity for the elution lane (E) was approximately three 
times that for the final wash (W10) in round 3, confirming that oligonucleotides that could bind to BA-glucose 
mixture were successfully isolated (Fig. 4b and Supplementary Information, Figure S8).
Affinity of Aptamers. We measured the affinity of the enriched aptamer candidate pools that resulted from 
microfluidic SELEX, as well as individual sequences selected from the pools (Supplementary Information, Figure S10). 
For IgE-targeting aptamers, we used a fluorescence binding assay in which target immobilized on beads were 
exposed to varying concentrations of fluorescently labeled oligonucleotides, and the amount of oligonucleotides 
initially bound to the targets were thermally released and quantitatively estimated25. For the enriched pool of 
IgE-binding aptamer candidates, the fluorescence intensity, indicative of the amount of IgE-oligonucleotide 
complexes, increased rapidly and reached saturation at low oligonucleotide concentrations (below ~30 nM). 
The equilibrium dissociation constant (KD) of the enriched aptamer candidate pool to the immobilized IgE was 
estimated to be 15 ± 1.5 nM. The fluorescence intensity from control experiments using the randomized oligo-
nucleotide library versus IgE increased very slowly with the oligonucleotide concentration (Fig. 5a), indicat-
ing negligible target-binding affinity of the library. Moreover, fluorescence measurements of the enriched pool 
versus IgG (data not shown) showed negligible binding, verifying that the oligonucleotides in the pool were 
specific to IgE. The oligonucleotide sequences SIGE5 and SIGE7, which have a hairpin loop secondary structure, 
(Supplementary Information, Figure S9), from the pool showed strong binding to IgE with KD = 10 ± 2.1 nM 
and KD = ~18 ± 3.6 nM, respectively. These affinities are comparable to anti-IgE aptamers (KD = ~10–35 nM48) 
Figure 4. Gel electropherograms showing progress in the isolation of target-binding aptamer candidates 
during multi-round microfluidic SELEX. Bar graphs depict the band intensity in the gel images from eluents 
collected during the SELEX process for (a) IgE and (b) BA-glucose mixture. Lane W: wash; Lane C: counter 
selection; Lane E: elution.
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isolated using conventional SELEX methods. The sequences were also determined to be specific to IgE by show-
ing negligible affinity to the counter target IgG (Fig. 5b,c). The improved binding interactions between targets 
and oligonucleotides within microscale volumes, as suggested by previous studies involving single-step aptamer 
selection in small volumes25,54, could be responsible for aptamers to be successfully isolated in the small number 
(three) of rounds.
We also estimated the affinity of aptamer candidates isolated against the BA-glucose mixture as the 
target. The enriched aptamer candidate pool or sequences selected from the pool were initially captured by the 
bead-immobilized ssDNA anchor, and then released by exposure to different concentrations of the BA-glucose 
mixture55. The fluorescence intensity from measurements using the enriched aptamer candidate pool (Fig. 5d) as 
well as the selected sequences SBG2 (Fig. 5e and Figure S9c) and SBG5 (Fig. 5f and Supplementary Information, 
Figure S9) exhibited a rapid increase at target concentrations below ~5 μ M followed by a slow increase at higher 
target concentrations. In comparison, the fluorescence intensity from control experiments using randomized 
oligonucleotides was substantially lower at all target concentrations, confirming the affinity of the aptamer can-
didates toward the BA-glucose mixture. The half-maximum concentration, i.e., the target concentration at which 
the fluorescence intensity reaches 50% of the saturation value (as achieved at high target concentrations)56, was 
approximately 5 ± 1.7 μ M. Similarly, the half-maximum concentration for SBG2 and SBG5 against the BA-glucose 
mixture was estimated to be 2 ± 0.7 μ M and 1 ± 0.5 μ M, respectively, also suggesting strong interactions with the 
target. Further studies would be required to confirm that the oligonucleotides obtained from the microfluidic 
SELEX processes can function as solution-phase aptamers57 for glucose.
Conclusions
We described a microfluidic approach to integrated isolation of aptamers against biological targets. The approach 
employs a microbead-based protocol for the processes of affinity selection and amplification of target-binding 
oligonucleotides, and an electrophoretic oligonucleotide manipulation scheme for effective two-way coupling 
of these processes, which are required to occur in different buffers. The entire iterative SELEX process is hence 
integrated on a single chip and does not require any offline procedures, thereby enabling highly efficient isolation 
of aptamers in drastically reduced times and with minimized consumption of biological material. In addition, 
the approach as such affords broad target applicability by allowing selection of aptamers with respect to targets 
that are either surface-immobilized or solution-borne, potentially allowing aptamers to be developed as readily 
available affinity reagents for a wide range of targets.
We demonstrated the utility of this microfluidic SELEX approach on two different procedures, respectively for 
isolating aptamers against immunoglobulin E as a representative surface-immobilized protein, and bisboronic 
acid-glucose mixture as a representative solution-borne target. For both targets, the SELEX process was com-
pleted in three rounds within a total process time of approximately 10 hours. The resulting aptamer candidates 
exhibited strong target-binding affinity, with an equilibrium dissociation constant of 18 nM or better toward 
Figure 5. Target-binding affinity of aptamer candidates resulting from microfluidic SELEX. Fluorescence 
intensity was measured of thermally released oligonucleotides that bound to bead-immobilized IgE: (a) the 
enriched aptamer candidate pool and randomized oligonucleotide library, and the sequences (b) SIGE5 and 
(c) SIGE7 selected from the enriched pool. Fluorescence intensity was obtained for gel electrophoresis bands of 
oligonucleotides released from bead-immobilized ssDNA anchor due to binding to BA-glucose mixture: (d) the 
enriched aptamer candidate pool and randomized library, and the sequences (e) SBG2 and (f) SBG5 selected 
from the enriched pool.
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immunoglobulin E, and a half-maximum concentration of 2 μ M or better toward the bisboronic acid-glucose 
mixture.
The microfluidic SELEX experiments were performed on a PDMS-based microchip. While the adequacy of 
PDMS as the proof-of-concept material was indicated by the consistent and repeatable results from repeated 
experiments as well as the successful isolation of aptamer candidates, other microchip materials could readily 
be used to offer desired properties for specific intended applications. Additionally, the microchip could be fur-
ther instrumented and programmed to allow fully automated operation. Thus, we envision that the microfluidic 
SELEX approach can enable broader use of aptamers by potentially allowing low-cost, rapid and automated dis-
covery of oligonucleotide-based receptors for a diverse range of targets.
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